Arthramid Vet (2.5% polyacrylamide hydrogel) - formulation, mode of action, published research, use

Equine vets Dr Leigh de Clifford and Dr Jason Lowe present this webinar on Arthramid Vet, a 2.5% polyacrylamide hydrogel that is registered in New Zealand for treatment of osteoarthritis in horses. They outline the formulation of the product and give extensive details on its mode of action. The webinar also covers various published research papers over a number of years. Indications for use for Arthramid Vet are explored as well as dose rates and post injection protocols. Arthramid Vet is registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596.